UBRELVY

Abbvie Corporation🇨🇦 Health Canada

Approval Id: ca7c85859a812087
Drug Approval Canada Name: UBRELVY
Product Name: UBRELVY
Status: Marketed
Status Date: 2023-05-11
Original Market Date: 2023-05-11
Din: 02532530
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 28:32.12
Atc Original: N02CD04 UBROGEPANT
Atc Name: n 02 cd 04
Aig Number: 0164241001
Company Name: Abbvie Corporation
Company Address: 8401 Trans-Canada Highway, Saint-Laurent, Quebec, Canada, H4S 1Z1
Company Detail Path: /organization/abbvie-corporation

UBROGEPANT

50 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

ca7c85859a812087

Type

Standard